FDA Proposes New Rules for Tobacco Product Manufacturing

Mar.09.2023
FDA Proposes New Rules for Tobacco Product Manufacturing
The FDA proposes new rules for tobacco product manufacturing to protect public health and ensure consistency and reduce contamination.

US regulatory agency will seek input from advisory committees and the general public regarding proposed regulations.


The United States Food and Drug Administration (FDA) has proposed new requirements for the manufacturing, design, packaging, and storage of electronic cigarettes and other tobacco products. The proposed regulations aim to protect public health, minimize or prevent contamination, limit additional risks, and ensure product consistency.


The proposed regulations apply to manufacturers of both finished and bulk electronic cigarettes and other tobacco products. Under the proposed rules, finished tobacco products refer to any component or part of a tobacco product that is packaged in the final packaging, such as electronic cigarettes, cigarette packaging, or wet tobacco cans. Bulk tobacco products refer to tobacco products that are not packaged in the final packaging but are suitable for consumer use.


This proposed new regulation will be beneficial for manufacturers.


Adhere to the Federal Food, Drug and Cosmetic Act and take measures to minimize or prevent contamination in tobacco products, such as metals, glass, and plastics.


Solution to the problem of inconsistency between electronic cigarette e-liquid product labels and actual concentration.


3. Establish requirements related to identification, traceability, and correction of tobacco products that do not meet specifications or have been contaminated, including those already distributed.


If issues arise, these regulations will require manufacturers to take corrective action, which might include initiating a recall.


The proposed rules establish a framework for manufacturers to comply with, which includes:


Establish a mechanism for controlling the design and development of tobacco products.


B. Ensure that the production of finished and loose tobacco products meets established standards.


C. Aim to minimize the production and distribution of tobacco products that do not meet industry standards.


D. It is demanded that manufacturers must take appropriate measures to prevent contamination of tobacco products.


Demanding an investigation and identification of non-compliant products in order to take appropriate corrective measures such as recalling them.


Establish the ability to track all components, parts, ingredients, additives, and materials, as well as each batch of finished or loose tobacco products, in order to assist in investigating those products that do not meet the specifications.


The FDA will hold a public hearing on April 12 to collect opinions from various stakeholders, including the industry, scientific community, advocacy groups, and the public. The proposed rules will also be open for public comment for 180 days. The FDA will review all comments.


The FDA will convene a meeting of the Tobacco Products Scientific Advisory Committee (TPSAC) on May 18 to seek recommendations from external expert groups. As part of the TPSAC meeting, the public will have an opportunity to provide verbal statements. The FDA intends to publish TPSAC meeting materials on its website no later than 48 hours before the meeting begins.


2FIRSTS will conduct interviews with individuals affected by the new regulations and continue to report on the matter.


Reference:


The U.S. Food and Drug Administration (FDA) has put forward new regulations for the manufacturing of vaping products.


The Food and Drug Administration (FDA) has put forth new regulations regarding the production practices of tobacco products. These requirements aim to improve the manufacturing standards of tobacco products in order to reduce their harmful effects on consumers.


The Proposed Rule titled "Requirements for Tobacco Product Manufacturing Practice" has been introduced.


The Tobacco Products Scientific Advisory Committee (TPSAC) convened for a meeting.


Public hearing to discuss proposed regulations for tobacco product manufacturing practices.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Scandinavian Tobacco Group releases 2025 results: tariffs and weaker demand weigh on performance, revenue about $1.4 billion
Scandinavian Tobacco Group releases 2025 results: tariffs and weaker demand weigh on performance, revenue about $1.4 billion
Scandinavian Tobacco Group (STG) reported its 2025 results: revenue was 9.036 billion Danish kroner (about $1.407 billion); EBITDA before special items was 1.791 billion Danish kroner (about $278 million); and free cash flow before acquisitions was 595 million Danish kroner (about $92.7 million). Multiple metrics declined year over year, and the company did not meet its Q3-updated guidance for revenue and free cash flow.
Mar.05 by 2FIRSTS.ai
UKVIA Says VApril 2026 Will Highlight Consumer Impact of Tobacco and Vapes Bill
UKVIA Says VApril 2026 Will Highlight Consumer Impact of Tobacco and Vapes Bill
The UK Vaping Industry Association said it will launch the ninth annual VApril campaign next month. The association described VApril as the world’s largest vape awareness initiative and said it has for almost a decade supported adult smokers looking to quit through vaping by providing evidence-based information, expert insights and practical guidance
Mar.24 by 2FIRSTS.ai
FDA Says Flavored ENDS Must Show “Added Benefit” as Small Manufacturers Seek Clearer Switching Benchmarks
FDA Says Flavored ENDS Must Show “Added Benefit” as Small Manufacturers Seek Clearer Switching Benchmarks
During the FDA PMTA roundtable session on “Studies of Adult Benefit,” officials said flavored ENDS must demonstrate “added benefit” over tobacco-flavored products under the APPH standard, including sustained complete switching evidence. Small manufacturers questioned switching benchmarks, study duration, and bridging expectations.
Feb.11
EVO NXT: two days, four zones, countless opportunities
EVO NXT: two days, four zones, countless opportunities
Mar.30
Special Report | Middle East Military Conflict Disrupts Global Air Corridors: Europe-Bound Vape Logistics Defy Seasonal Price Declines, Fuel Cost Risks Emerge
Special Report | Middle East Military Conflict Disrupts Global Air Corridors: Europe-Bound Vape Logistics Defy Seasonal Price Declines, Fuel Cost Risks Emerge
Escalating tensions involving Iran are disrupting air transit routes heavily used for China’s vape exports to Europe, preventing the usual post–Lunar New Year freight rate decline. While Europe-bound capacity reliant on Middle East hubs faces pressure, shipments to the United States remain largely unaffected for now. However, potential jet fuel price increases could broaden cost pressures globally.
Special Report
Mar.02
Andy Tan Named 2026 SRNT Fellow for Contributions to Nicotine Research
Andy Tan Named 2026 SRNT Fellow for Contributions to Nicotine Research
Andy Tan, Ph.D., has been named a 2026 Fellow of the Society for Research on Nicotine and Tobacco (SRNT), an international professional association dedicated to advancing nicotine and tobacco research. Fellows are selected for outstanding research contributions as well as leadership, mentoring, and policy engagement within the field.
Feb.23